Quoin Pharmaceuticals, Ltd.
QNRX
$7.20
-$0.0796-1.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.70M | -3.81M | -2.31M | -2.35M | -1.97M |
| Total Depreciation and Amortization | 25.00K | 25.00K | 25.00K | 25.00K | 25.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 247.60K | 293.30K | 261.30K | 247.60K | 289.10K |
| Change in Net Operating Assets | -262.90K | 899.70K | -211.50K | -102.00K | -347.20K |
| Cash from Operations | -3.69M | -2.59M | -2.24M | -2.18M | -2.01M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.68M | 2.77M | -3.18M | 2.60M | 3.16M |
| Cash from Investing | 1.68M | 2.77M | -3.18M | 2.60M | 3.16M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -150.00K | -150.00K | -150.00K | -150.00K | -150.00K |
| Issuance of Common Stock | 0.00 | 173.00K | 6.07M | 100.00 | 13.70K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -150.00K | 23.00K | 5.92M | -149.90K | -136.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.15M | 198.80K | 506.60K | 271.60K | 1.01M |